KPA to press Roche Korea over returned stock issue.

Roche Korea has emerged as one of the uncooperative companies to the Korea Pharmaceutical Association over the returned stock issue, and therefore the KPA is strongly giving a pressure to Roche.

The KPA filed an administrative measure to the KFDA for Caldivita chewable tablets and Madopar tablets, by claiming that a lot of damages for Caldivita chewable tablets were reported and recently se...